# FDA Inspection 1198365 - BioPharma Services, Inc. - October 27, 2022

Source: https://www.keypedia.com/records/fda_inspections/biopharma-services-inc/9b3e773a-c498-4865-996c-81d16fa678aa
Source feed: FDA_Inspections

> FDA Inspection 1198365 for BioPharma Services, Inc. on October 27, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1198365
- Company Name: BioPharma Services, Inc.
- Inspection Date: 2022-10-27
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1171309 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/biopharma-services-inc/35d53fc8-d34f-4552-828a-084bcc381435)
- [FDA Inspection 1101801 - 2019-08-09](https://www.keypedia.com/records/fda_inspections/biopharma-services-inc/785348ac-bb83-416f-a193-cb4971e7e329)
- [FDA Inspection 1067816 - 2018-08-31](https://www.keypedia.com/records/fda_inspections/biopharma-services-inc/d0d9a6e0-2340-4702-bac7-f6aaf11dcada)

Company: https://www.keypedia.com/companies/biopharma-services-inc/da8e4cb9-f355-4d9f-94d2-ff09907ea84d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c